Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Condliffe, N. Woodhouse, C. A. Elliot, J. Wild, D. Hagger, I. J. Armstrong, C. Davies, C. Hill, D. G. Kiely (Sheffield, United Kingdom). Haemodynamic correlation and prognostic value of ventricular mass index (VMI) in non-surgically treated chronic thromboembolic pulmonary hypertension (CTEPH). Eur Respir J 2008; 32: Suppl. 52, 1424

Member's Comments

No comment yet.

Related content which might interest you: Accuracy of pre-operative specimen level prediction in chronic thromboembolic pulmonary hypertension (CTEPH) patients undergoing pulmonary thromboendarterectomy (PTE) Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 RV/TLC ratio as an independent prognostic indicator in idiopathic pulmonary arterial hypertension (IPAH) Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Prognostic value of ventricular volumes and function in patients with pulmonary hypertension due to chronic obstructive pulmonary disease Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging Year: 2012 Right heart volume load response in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 Effect of riociguat on haemodynamic parameters and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension Year: 2009 Relation between hemodynamics and right ventricular hypertrophy may affect survival and severity of the disease in patients with primary pulmonary hypertension (PPH) Source: Eur Respir J 2002; 20: Suppl. 38, 26s Year: 2002 Right ventricular (RV) diastolic function in patients with pulmonary hypertension (PH) due to chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 26s Year: 2002 Right ventricular function is a strong prognostic predictor of mortality in pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 The assessment of heart chambers volumes using modified transpulmonary thermodilution in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Clinical and prognostic value of atrial natriutic peptide in patients with idiopathic pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 659s Year: 2006 Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 Prognostic value of right ventricular dilatation in patients with low risk pulmonary embolism Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 The long-term prognostic value of extracted thrombus and hemodynamics and in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers Year: 2012 Right ventricular dimensions on CTPA predict pulmonary hypertension and prognosis in interstitial lung disease (ILD) Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Prognostic significance of right ventricular dysfunction detected by CT/Echocardiography and biomarkers in normotensive patients with pulmonary embolism Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Initial dual oral combination therapy prior to pulmonary endarterectomy (PEA) in patients with operable chronic thromboembolic pulmonary hypertension (CTEPH) and high preoperative pulmonary vascular resistance (PVR) Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Is there a fixed relationship between the mean and systolic pulmonary artery pressures in idiopathic pulmonary arterial hypertension (IPAH) and proximal chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2009 - Pulmonary embolism Year: 2009 Impact of two 5-year anticoagulant strategies on survival and echocardiographic parameters in the patients with chronic thromboembolic pulmonary hypertension (CTEPH) who did not undergo pulmonary endarterectomy Source: Annual Congress 2004 - Pulmonary embolism Year: 2004 Right ventricular (RV) morphometric and ventriculo-vascular (VV) coupling patterns in patients with advanced pulmonary arterial hypertension (PAH) undergoing parenteral treprostinil therapy Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 In patients with intermediate-low risk pulmonary embolism: cardiac enzyme or right ventricle dysfunction or sPESI Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017